# Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pharmacology-of-nicotine-and-its-therapeutic-use-in-smoking-cessation-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David J.K. Balfour,Karl Fagerström |
| Citations | 197 |
| DOI | 10.1016/s0163-7258(96)00099-x |
| Fields | Biochemistry, Genetics and Molecular Biology,Chemistry,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1991978791 |
| PMID | 8981571 |
| Type | article |
| Year | 1996 |

## Paper authors

- [Karl Fagerström](https://scholariq.org/researchers/karl-fagerstrom/)

## Paper journal

- [Pharmacology & Therapeutics](https://scholariq.org/journals/pharmacology-and-therapeutics/)

## Paper primary topic

- [Nicotinic Acetylcholine Receptors Study](https://scholariq.org/topics/nicotinic-acetylcholine-receptors-study/)

## Paper topics

- [Nicotinic Acetylcholine Receptors Study](https://scholariq.org/topics/nicotinic-acetylcholine-receptors-study/)
- [Smoking Behavior and Cessation](https://scholariq.org/topics/smoking-behavior-and-cessation/)
- [Synthesis and Biological Evaluation](https://scholariq.org/topics/synthesis-and-biological-evaluation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.